Entry |
|
Symbol |
PIK3R2, MPPH, MPPH1, P85B, p85, p85-BETA, p85beta
|
Name |
(RefSeq) phosphoinositide-3-kinase regulatory subunit 2
|
KO |
K02649 | phosphoinositide-3-kinase regulatory subunit alpha/beta/delta |
|
Organism |
|
Pathway |
hsa01521 | EGFR tyrosine kinase inhibitor resistance |
hsa04070 | Phosphatidylinositol signaling system |
hsa04072 | Phospholipase D signaling pathway |
hsa04213 | Longevity regulating pathway - multiple species |
hsa04550 | Signaling pathways regulating pluripotency of stem cells |
hsa04613 | Neutrophil extracellular trap formation |
hsa04620 | Toll-like receptor signaling pathway |
hsa04625 | C-type lectin receptor signaling pathway |
hsa04650 | Natural killer cell mediated cytotoxicity |
hsa04660 | T cell receptor signaling pathway |
hsa04662 | B cell receptor signaling pathway |
hsa04664 | Fc epsilon RI signaling pathway |
hsa04666 | Fc gamma R-mediated phagocytosis |
hsa04670 | Leukocyte transendothelial migration |
hsa04750 | Inflammatory mediator regulation of TRP channels |
hsa04810 | Regulation of actin cytoskeleton |
hsa04914 | Progesterone-mediated oocyte maturation |
hsa04919 | Thyroid hormone signaling pathway |
hsa04923 | Regulation of lipolysis in adipocytes |
hsa04932 | Non-alcoholic fatty liver disease |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications |
hsa04935 | Growth hormone synthesis, secretion and action |
hsa04960 | Aldosterone-regulated sodium reabsorption |
hsa04973 | Carbohydrate digestion and absorption |
hsa05100 | Bacterial invasion of epithelial cells |
hsa05163 | Human cytomegalovirus infection |
hsa05166 | Human T-cell leukemia virus 1 infection |
hsa05167 | Kaposi sarcoma-associated herpesvirus infection |
hsa05168 | Herpes simplex virus 1 infection |
hsa05170 | Human immunodeficiency virus 1 infection |
hsa05207 | Chemical carcinogenesis - receptor activation |
hsa05208 | Chemical carcinogenesis - reactive oxygen species |
hsa05230 | Central carbon metabolism in cancer |
hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
hsa05418 | Fluid shear stress and atherosclerosis |
|
Network |
|
Element |
N01165 | PDL/PD1-SHP-PI3K signaling pathway |
N01656 | GF-RTK-PI3K signaling pathway |
N01658 | GF-RTK-RAS-PI3K signaling pathway |
N01695 | BCR-BCAP/CD19-PI3K signaling pathway |
N01696 | ICOSLG/ICOS-PI3K signaling pathway |
N01708 | INS-AKT signaling pathway |
|
Disease |
H01885 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
5296 (PIK3R2)
04014 Ras signaling pathway
5296 (PIK3R2)
04015 Rap1 signaling pathway
5296 (PIK3R2)
04370 VEGF signaling pathway
5296 (PIK3R2)
04630 JAK-STAT signaling pathway
5296 (PIK3R2)
04668 TNF signaling pathway
5296 (PIK3R2)
04066 HIF-1 signaling pathway
5296 (PIK3R2)
04068 FoxO signaling pathway
5296 (PIK3R2)
04070 Phosphatidylinositol signaling system
5296 (PIK3R2)
04072 Phospholipase D signaling pathway
5296 (PIK3R2)
04071 Sphingolipid signaling pathway
5296 (PIK3R2)
04024 cAMP signaling pathway
5296 (PIK3R2)
04151 PI3K-Akt signaling pathway
5296 (PIK3R2)
04152 AMPK signaling pathway
5296 (PIK3R2)
04150 mTOR signaling pathway
5296 (PIK3R2)
09133 Signaling molecules and interaction
04081 Hormone signaling
5296 (PIK3R2)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
5296 (PIK3R2)
09143 Cell growth and death
04210 Apoptosis
5296 (PIK3R2)
04218 Cellular senescence
5296 (PIK3R2)
09144 Cellular community - eukaryotes
04510 Focal adhesion
5296 (PIK3R2)
04550 Signaling pathways regulating pluripotency of stem cells
5296 (PIK3R2)
09142 Cell motility
04810 Regulation of actin cytoskeleton
5296 (PIK3R2)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
5296 (PIK3R2)
04613 Neutrophil extracellular trap formation
5296 (PIK3R2)
04620 Toll-like receptor signaling pathway
5296 (PIK3R2)
04625 C-type lectin receptor signaling pathway
5296 (PIK3R2)
04650 Natural killer cell mediated cytotoxicity
5296 (PIK3R2)
04660 T cell receptor signaling pathway
5296 (PIK3R2)
04662 B cell receptor signaling pathway
5296 (PIK3R2)
04664 Fc epsilon RI signaling pathway
5296 (PIK3R2)
04666 Fc gamma R-mediated phagocytosis
5296 (PIK3R2)
04670 Leukocyte transendothelial migration
5296 (PIK3R2)
04062 Chemokine signaling pathway
5296 (PIK3R2)
09152 Endocrine system
04910 Insulin signaling pathway
5296 (PIK3R2)
04923 Regulation of lipolysis in adipocytes
5296 (PIK3R2)
04929 GnRH secretion
5296 (PIK3R2)
04915 Estrogen signaling pathway
5296 (PIK3R2)
04914 Progesterone-mediated oocyte maturation
5296 (PIK3R2)
04917 Prolactin signaling pathway
5296 (PIK3R2)
04926 Relaxin signaling pathway
5296 (PIK3R2)
04935 Growth hormone synthesis, secretion and action
5296 (PIK3R2)
04919 Thyroid hormone signaling pathway
5296 (PIK3R2)
09154 Digestive system
04973 Carbohydrate digestion and absorption
5296 (PIK3R2)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
5296 (PIK3R2)
09156 Nervous system
04725 Cholinergic synapse
5296 (PIK3R2)
04722 Neurotrophin signaling pathway
5296 (PIK3R2)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
5296 (PIK3R2)
09158 Development and regeneration
04360 Axon guidance
5296 (PIK3R2)
04380 Osteoclast differentiation
5296 (PIK3R2)
09149 Aging
04211 Longevity regulating pathway
5296 (PIK3R2)
04213 Longevity regulating pathway - multiple species
5296 (PIK3R2)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
5296 (PIK3R2)
05206 MicroRNAs in cancer
5296 (PIK3R2)
05205 Proteoglycans in cancer
5296 (PIK3R2)
05207 Chemical carcinogenesis - receptor activation
5296 (PIK3R2)
05208 Chemical carcinogenesis - reactive oxygen species
5296 (PIK3R2)
05203 Viral carcinogenesis
5296 (PIK3R2)
05230 Central carbon metabolism in cancer
5296 (PIK3R2)
05231 Choline metabolism in cancer
5296 (PIK3R2)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
5296 (PIK3R2)
09162 Cancer: specific types
05210 Colorectal cancer
5296 (PIK3R2)
05212 Pancreatic cancer
5296 (PIK3R2)
05225 Hepatocellular carcinoma
5296 (PIK3R2)
05226 Gastric cancer
5296 (PIK3R2)
05214 Glioma
5296 (PIK3R2)
05221 Acute myeloid leukemia
5296 (PIK3R2)
05220 Chronic myeloid leukemia
5296 (PIK3R2)
05218 Melanoma
5296 (PIK3R2)
05211 Renal cell carcinoma
5296 (PIK3R2)
05215 Prostate cancer
5296 (PIK3R2)
05213 Endometrial cancer
5296 (PIK3R2)
05224 Breast cancer
5296 (PIK3R2)
05222 Small cell lung cancer
5296 (PIK3R2)
05223 Non-small cell lung cancer
5296 (PIK3R2)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
5296 (PIK3R2)
05170 Human immunodeficiency virus 1 infection
5296 (PIK3R2)
05161 Hepatitis B
5296 (PIK3R2)
05160 Hepatitis C
5296 (PIK3R2)
05171 Coronavirus disease - COVID-19
5296 (PIK3R2)
05164 Influenza A
5296 (PIK3R2)
05162 Measles
5296 (PIK3R2)
05168 Herpes simplex virus 1 infection
5296 (PIK3R2)
05163 Human cytomegalovirus infection
5296 (PIK3R2)
05167 Kaposi sarcoma-associated herpesvirus infection
5296 (PIK3R2)
05169 Epstein-Barr virus infection
5296 (PIK3R2)
05165 Human papillomavirus infection
5296 (PIK3R2)
09171 Infectious disease: bacterial
05131 Shigellosis
5296 (PIK3R2)
05135 Yersinia infection
5296 (PIK3R2)
05100 Bacterial invasion of epithelial cells
5296 (PIK3R2)
09174 Infectious disease: parasitic
05146 Amoebiasis
5296 (PIK3R2)
05142 Chagas disease
5296 (PIK3R2)
09164 Neurodegenerative disease
05010 Alzheimer disease
5296 (PIK3R2)
05017 Spinocerebellar ataxia
5296 (PIK3R2)
05020 Prion disease
5296 (PIK3R2)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
5296 (PIK3R2)
05418 Fluid shear stress and atherosclerosis
5296 (PIK3R2)
05415 Diabetic cardiomyopathy
5296 (PIK3R2)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
5296 (PIK3R2)
04932 Non-alcoholic fatty liver disease
5296 (PIK3R2)
04931 Insulin resistance
5296 (PIK3R2)
04933 AGE-RAGE signaling pathway in diabetic complications
5296 (PIK3R2)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
5296 (PIK3R2)
01524 Platinum drug resistance
5296 (PIK3R2)
01522 Endocrine resistance
5296 (PIK3R2)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:hsa04131]
5296 (PIK3R2)
Membrane trafficking [BR:hsa04131]
Endocytosis
Rab GTPases and associated proteins
Rab associated proteins
5296 (PIK3R2)
|
SSDB |
|
Motif |
|
Other DBs |
|
Structure |
|
LinkDB |
|
Position |
19:18153163..18170532
|
AA seq |
728 aa
MAGPEGFQYRALYPFRRERPEDLELLPGDVLVVSRAALQALGVAEGGERCPQSVGWMPGL
NERTRQRGDFPGTYVEFLGPVALARPGPRPRGPRPLPARPRDGAPEPGLTLPDLPEQFSP
PDVAPPLLVKLVEAIERTGLDSESHYRPELPAPRTDWSLSDVDQWDTAALADGIKSFLLA
LPAPLVTPEASAEARRALREAAGPVGPALEPPTLPLHRALTLRFLLQHLGRVASRAPALG
PAVRALGATFGPLLLRAPPPPSSPPPGGAPDGSEPSPDFPALLVEKLLQEHLEEQEVAPP
ALPPKPPKAKPASTVLANGGSPPSLQDAEWYWGDISREEVNEKLRDTPDGTFLVRDASSK
IQGEYTLTLRKGGNNKLIKVFHRDGHYGFSEPLTFCSVVDLINHYRHESLAQYNAKLDTR
LLYPVSKYQQDQIVKEDSVEAVGAQLKVYHQQYQDKSREYDQLYEEYTRTSQELQMKRTA
IEAFNETIKIFEEQGQTQEKCSKEYLERFRREGNEKEMQRILLNSERLKSRIAEIHESRT
KLEQQLRAQASDNREIDKRMNSLKPDLMQLRKIRDQYLVWLTQKGARQKKINEWLGIKNE
TEDQYALMEDEDDLPHHEERTWYVGKINRTQAEEMLSGKRDGTFLIRESSQRGCYACSVV
VDGDTKHCVIYRTATGFGFAEPYNLYGSLKELVLHYQHASLVQHNDALTVTLAHPVRAPG
PGPPPAAR |
NT seq |
2187 nt +upstreamnt +downstreamnt
atggcgggccctgagggcttccagtaccgcgctctgtacccgttccgccgggagcggccg
gaggacctggagctgctgcccggcgacgtgctggtagtgagccgggcggccttgcaggcg
ctgggcgtggccgagggtggcgagcgctgcccacagagcgtgggctggatgcccggcctc
aacgagcgcacacggcagcgaggtgacttccctggcacctatgtggagttcctggggccc
gtggccctggcccggcccggccctcgcccacggggcccccgcccactgcccgccaggccc
cgtgatggggcccctgagccaggcctcacactccccgacttgcccgagcagttctcccca
cctgatgtggctccccctcttctggtgaagcttgtggaggccattgaaaggacagggctg
gacagcgaatctcactaccgcccggagctgcccgcaccgcgtacagactggtccctgagc
gacgtggatcagtgggacacggcagccctggctgacggcattaagagcttcctgctggca
ctgcccgcgccgctcgtgacccccgaggcctcggccgaggcgcgccgggccctgcgggag
gccgcggggcccgtggggccggcgctggagccaccgacgctgccgctgcaccgcgcgctc
acgctgcgcttcctgctccagcacctgggccgcgtggccagccgcgccccggccctgggt
cccgcggtccgggccctgggcgccacctttgggccgctgctgctgcgcgcgccgccgccg
ccgtcctcgccgccgccagggggcgctcccgacgggagtgagcccagccctgacttcccg
gcgctgctggtggagaagctgcttcaggaacacttggaagagcaggaggttgcgccccca
gcgctgccgcctaaaccccccaaggcaaagccggcctccacagtcctggccaatggaggg
agcccaccctccctgcaggatgctgagtggtactggggggacatttcaagggaggaggtg
aacgagaaactccgggacactcccgatggcaccttcctagtccgagatgcttctagcaag
atccagggcgagtacacgctgaccctcaggaaaggcgggaacaataagctgatcaaggtc
ttccaccgagatgggcactatggcttctcagagccactcaccttctgctccgttgtggac
ctcatcaatcactaccgccacgagtctctggcccagtacaatgccaagctggacacacgg
ctcctctaccctgtgtccaaataccagcaggaccagattgtcaaggaggacagcgtggag
gcagtgggcgcccagcttaaggtctatcaccagcagtaccaggacaagagccgcgagtat
gaccagctttatgaagagtacacacggacctcccaggagctgcagatgaagcgtactgca
attgaggccttcaatgagactatcaagatctttgaagagcagggccagactcaagagaaa
tgcagcaaggaatacctggagcgcttccggcgtgagggcaacgagaaagagatgcaaagg
atcctgctgaactccgagcggctcaagtcccgcattgccgagatccatgagagccgcacg
aagctggagcagcagctgcgggcccaggcctcggacaacagagagatcgacaagcgcatg
aacagcctcaagccggacctcatgcagctgcgcaagatccgagaccagtacctcgtgtgg
ctcacccagaaaggcgcccggcagaagaaaatcaacgagtggctggggattaaaaatgag
actgaggaccagtacgcactcatggaggacgaggacgatctcccgcaccacgaggaacgc
acttggtacgtgggcaagatcaaccgcacgcaggcagaggagatgctgagtggcaagcgg
gatggcaccttcctcatccgcgagagcagccagcggggctgctacgcctgctccgtggta
gtggacggcgacaccaagcactgcgtcatctaccgcacggccaccggcttcggcttcgcg
gagccctacaacctgtacgggtcgctgaaggagctggtgctgcactaccagcacgcctcg
ctggtgcagcacaacgacgcgctcaccgtcaccctggcgcacccagtgcgcgccccgggc
cccggcccgccgcctgccgcccgctga |